BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 166 filers reported holding BLUEBIRD BIO INC in Q3 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $319,617 | +5.1% | 97,148 | +1.6% | 0.00% | 0.0% |
| Q1 2023 | $304,161 | -65.2% | 95,648 | -24.2% | 0.00% | -75.0% |
| Q4 2022 | $873,429 | -68.2% | 126,218 | +147.6% | 0.00% | -69.2% |
| Q3 2020 | $2,750,000 | -24.3% | 50,974 | -14.3% | 0.01% | -23.5% |
| Q2 2020 | $3,633,000 | -35.1% | 59,511 | +67.2% | 0.02% | -45.2% |
| Q1 2019 | $5,599,000 | +379.4% | 35,585 | +202.2% | 0.03% | +342.9% |
| Q4 2018 | $1,168,000 | -73.4% | 11,775 | -60.9% | 0.01% | -69.6% |
| Q3 2018 | $4,394,000 | -79.3% | 30,097 | -77.7% | 0.02% | -80.3% |
| Q2 2018 | $21,202,000 | +600.9% | 135,086 | +662.5% | 0.12% | +588.2% |
| Q1 2018 | $3,025,000 | +64.0% | 17,716 | +71.1% | 0.02% | +70.0% |
| Q4 2017 | $1,845,000 | +184.7% | 10,357 | +119.5% | 0.01% | +150.0% |
| Q3 2017 | $648,000 | – | 4,718 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sessa Capital IM, L.P. | 1,834,965 | $35,066,000 | 1.72% |
| Birchview Capital, LP | 84,000 | $1,605,000 | 1.09% |
| ARMISTICE CAPITAL, LLC | 2,472,000 | $47,240,000 | 0.80% |
| EcoR1 Capital, LLC | 802,507 | $15,336,000 | 0.53% |
| Parametrica Management Ltd | 36,919 | $706,000 | 0.53% |
| Bain Capital Life Sciences Investors, LLC | 538,179 | $7,239,000 | 0.45% |
| APPLETON GROUP, LLC | 19,495 | $373,000 | 0.32% |
| MANGROVE PARTNERS IM, LLC | 175,587 | $3,355,000 | 0.30% |
| Quinn Opportunity Partners LLC | 230,100 | $4,397,000 | 0.28% |
| PDT Partners, LLC | 171,700 | $3,281,000 | 0.24% |